Evidence map›Paper›PMID 42676648›Full record

ArticleFrontiers in public health2026

Describing the outcomes and factors of using pathogen genomic results in public health.

James D H Ong, Tehzeeb Zulfiqar, Daisy Wang, Stephanie Panchision, Aaliya Ibrahim, Kathryn Glass, Martyn D Kirk, Brad Astbury, Angeline Ferdinand

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

James D H OngCentre for Pathogen Genomics, Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.
Tehzeeb ZulfiqarNational Centre for Epidemiology and Population Health, College of Law, Governance and Policy, Australian National University, Canberra, ACT, Australia.
Daisy WangNational Centre for Epidemiology and Population Health, College of Law, Governance and Policy, Australian National University, Canberra, ACT, Australia.
Stephanie PanchisionNational Centre for Epidemiology and Population Health, College of Law, Governance and Policy, Australian National University, Canberra, ACT, Australia.
Aaliya IbrahimNational Centre for Epidemiology and Population Health, College of Law, Governance and Policy, Australian National University, Canberra, ACT, Australia.
Kathryn GlassNational Centre for Epidemiology and Population Health, College of Law, Governance and Policy, Australian National University, Canberra, ACT, Australia.
Martyn D KirkNational Centre for Epidemiology and Population Health, College of Law, Governance and Policy, Australian National University, Canberra, ACT, Australia.
Brad AstburyEvaluation and Implementation Science Unit, Centre for Health Policy, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
Angeline FerdinandCentre for Pathogen Genomics, Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although many countries are incorporating pathogen genomics into their public health systems, previous studies rarely examine their implementation, use and outcomes. This study describes how pathogen genomics is implemented and used in public health to guide surveillance and outbreak responses against infectious disease. Methods: We examined 11 case studies of pathogen genomics use in surveillance programs and outbreak responses against infectious disease across Australia and New Zealand. Information on each case study was collected via document review and key informant interviews and summarized in case reports. Case reports were then compared to identify similarities and differences in outcomes and factors. Results: Although pathogen genomics served various functions in supporting public health investigations and responses against infectious disease, their impact varied. This ranged from providing information about a clinical case or public health response to informing changes in public health investigations and responses against infectious disease. Timeliness and novelty were two factors that appeared to distinguish the impact of pathogen genomics in public health among case studies. Other factors such as end users' literacy and attitudes were similar across case studies, but may help highlight the need for consistent processes to support implementation of pathogen genomics in public health. Conclusion: This study describes how pathogen genomics is being implemented across different pathogens and contexts in public health. These results will inform future research and implementation programs that aim to improve public health pathogen genomics programs. This may lead to enhanced use and outcomes to facilitate more tailored, timely and effective public health responses against infectious disease.

Indexed as

Communicable DiseasesDisease OutbreaksGenomicsPublic HealthAustraliaHumansNew Zealandantimicrobial resistancecase studiesimplementation scienceinfectious diseasepathogen genomicspathogensqualitative research

Identifiers

PMID42676648
PMCPMC13526924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.